2024    2023    2022    2021    2020    2019    2018    2017    2016   

2022

Articles

251 - 

Metabolic syndrome and prostate cancer in Afro-Caribbean men

Florian Lefebvre, Anne Blanchet-Deverly, Leah Michineau, Pascal Blanchet, Luc Multigner et al.

Prostate, 2022, 82 (3), pp.359-365.

DOI : https://doi.org/10.1002/pros.24281

Pubmed : 34905623

 

252 - 

Rare cause of life-threatening hypercalcemia in an infant: a case report Cause rare d’hypercalcémie gravissime chez l’enfant : cas clinique

C Lefevre, L Peltier, Anna Lokchine, A Ryckewaert, Caroline Moreau et al.

Rare cause of life-threatening hypercalcemia in an infant: a case report. Annales de Biologie Clinique, 2022, 80 (5), TT - Cause rare d’hypercalcémie gravissime chez l’enfant : cas clinique.

DOI : https://doi.org/10.1684/abc.2022.1747

Pubmed : 36453734

 

253 - 

Diagnosis and Risk Factors for Intracranial Aneurysms in Autosomal Polycystic Kidney Disease: A cross-sectional study from the Genkyst Cohort

Siriane Lefèvre, Marie-Pierre Audrézet, Jean-Michel Halimi, Hélène Longuet, Frank Bridoux et al.

Nephrology Dialysis Transplantation, In press,

DOI : https://doi.org/10.1093/ndt/gfac027

Pubmed : 35108395

 

254 - 

SMG6 localizes to the chromatoid body and shapes the male germ cell transcriptome to drive spermatogenesis

Tiina Lehtiniemi, Matthieu Bourgery, Lin Ma, Ammar Ahmedani, Margareeta Makela et al.

Nucleic Acids Research, 2022,

DOI : https://doi.org/10.1093/nar/gkac900

Pubmed : 36259644

 

255 - 

Characterization of multiple pesticide exposure in pregnant women in Brittany, France

Naomi Lejeune, Fabien Mercier, Cécile Chevrier, Nathalie Bonvallot, Barbara Le Bot et al.

Journal of Exposure Science and Environmental Epidemiology, 2022,

DOI : https://doi.org/10.1038/s41370-022-00507-9

Pubmed : 36496457

 

256 - 

Mega randomized clinical trials: a definitive solution or a double-edged sword?

Florian Lemaitre, Bruno Laviolle

European Journal of Clinical Pharmacology, 2022, 78 (2), pp.305-306.

DOI : https://doi.org/10.1007/s00228-021-03230-w

Pubmed : 34651199

 

257 - 

Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)

Florian Lemaitre, Matthieu Grégoire, Caroline Monchaud, Stéphane Bouchet, Béatrice Saint-Salvi et al.

Therapies, 2022, 77 (5), pp.509-521.

DOI : https://doi.org/10.1016/j.therap.2022.03.005

Pubmed : 35618549

 

258 - 

Has the Time Come for Systematic Therapeutic Drug Monitoring of First-line and WHO Group A Anti-tuberculosis Drugs?

Florian Lemaitre

Has the Time Come for Systematic Therapeutic Drug Monitoring of First-line and WHO Group A Anti-tuberculosis Drugs?. Therapeutic Drug Monitoring, 2022, 44 (1), pp.133-137.

DOI : https://doi.org/10.1097/FTD.0000000000000948

Pubmed : 34857693

 

259 - 

Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!

Florian Lemaitre

Clinical Pharmacokinetics, 2022, 61 (8), pp.1071-1073.

DOI : https://doi.org/10.1007/s40262-022-01158-7

Pubmed : 35870084

 

260 - 

How to Optimize Connection Between PACS and Clinical Data Warehouse: A Web Service Approach Based on Full Metadata Integration

Pierre Lemordant, Guillaume Bouzillé, Romain Mathieu, Ronan Thenault, Bernard Gibaud et al.

Studies in Health Technology and Informatics, 2022, 290, pp.27-31.

DOI : https://doi.org/10.3233/SHTI220025

Pubmed : 35672964